| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/18/1999 | US5905149 Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors |
| 05/18/1999 | US5905078 Treatment of neurohormonal imbalance |
| 05/18/1999 | US5905076 Treatment of muscular dystrophy, arthritis, myocardial infarction, alzheimer's disease, bacterial infection, common cold, osteoporosis or cancer metastasis |
| 05/18/1999 | US5904938 Anticoagulants using nitric oxide by breathing |
| 05/18/1999 | CA2040884C Process for the preparation of 1-(2,3,4-trimethoxybenzyl) piperazine by reductive amination |
| 05/14/1999 | WO1999023217A1 A novel gene and uses therefor |
| 05/14/1999 | WO1999023106A1 Caspase-14 polypeptides |
| 05/14/1999 | WO1999023105A1 Vegi, an inhibitor of angiogenesis and tumor growth |
| 05/14/1999 | WO1999023078A2 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists |
| 05/14/1999 | WO1999023077A1 Indazole bioisostere replacement of catechol in therapeutically active compounds |
| 05/14/1999 | WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | WO1999023075A1 Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents |
| 05/14/1999 | WO1999023072A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 05/14/1999 | WO1999022738A1 Compositions of lipid lowering agents |
| 05/14/1999 | WO1999022736A1 Use of quinapril for treating myocardial ischemia and angina |
| 05/14/1999 | WO1999022722A2 Use of macrolides for the treatment of cancer and macular degeneration |
| 05/14/1999 | WO1999022721A2 Unsubstituted polydiallylamine for treating hypercholesterolemia |
| 05/14/1999 | WO1999022714A1 Topical compositions for prostaglandin e1 delivery |
| 05/14/1999 | WO1999010338A3 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists |
| 05/14/1999 | WO1999007351A3 Indole derivatives and their use as mcp-1 antagonists |
| 05/14/1999 | WO1999003508A9 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 05/14/1999 | WO1998058915A3 Pyrimidin-2,4,6-trion derivatives and their use as metalloprotease-inhibitors |
| 05/14/1999 | WO1998052549B1 Use of fumaric acid derivatives |
| 05/14/1999 | WO1998051289A3 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 05/14/1999 | WO1998033904A3 An antisense oligonucleotide preparation method |
| 05/14/1999 | CA2681877A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 05/14/1999 | CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | CA2309165A1 Topical compositions for prostaglandin e1 delivery |
| 05/14/1999 | CA2309150A1 Indazole bioisostere replacement of catechol in therapeutically active compounds |
| 05/14/1999 | CA2308112A1 Caspase-14 polypeptides |
| 05/14/1999 | CA2307850A1 Use of macrolides for the treatment of cancer and macular degeneration |
| 05/14/1999 | CA2307839A1 Gene involved in metabolic energy and obesity |
| 05/14/1999 | CA2307770A1 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists |
| 05/14/1999 | CA2307097A1 Compositions of lipid lowering agents |
| 05/14/1999 | CA2300198A1 Use of quinapril for treating myocardial ischemia and angina |
| 05/12/1999 | EP0915090A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease |
| 05/12/1999 | EP0915088A1 D-Proline derivatives |
| 05/12/1999 | EP0915087A2 Sulfonamide substituted fused five-membered ring compounds, their use as medicaments as well as pharmaceutical compositions containing them |
| 05/12/1999 | EP0915086A1 Phenylsulfonamide derivatives |
| 05/12/1999 | EP0914828A2 Use of des-aspartate-angiotensin I |
| 05/12/1999 | EP0914821A2 Method for diagnosis of atherosclerosis involving measurement of NADPH oxidase activity |
| 05/12/1999 | EP0914459A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 05/12/1999 | EP0914456A1 Gene expression in monocytes and macrophages |
| 05/12/1999 | EP0914427A1 Plasmid-based vaccine for treating atherosclerosis |
| 05/12/1999 | EP0914426A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases |
| 05/12/1999 | EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 05/12/1999 | EP0914330A1 Novel compounds |
| 05/12/1999 | EP0914322A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| 05/12/1999 | EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 05/12/1999 | EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
| 05/12/1999 | EP0914146A1 Morphogen treatment for chronic renal failure |
| 05/12/1999 | EP0914128A1 Formulation and method for treating congestive heart failure |
| 05/12/1999 | EP0914124A1 ANTITHROMBOTIC AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION INCLUDING A THIENOPYRIDINE DERIVATIVE AND AN HMG-CoA-REDUCTASE INHIBITOR |
| 05/12/1999 | EP0914121A1 Medicaments for ameliorating endothelial cell activation |
| 05/12/1999 | EP0914119A2 Solid oral dosage forms of valsartan |
| 05/12/1999 | EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways |
| 05/12/1999 | EP0808162B1 Use of carbazole compounds for the manufacture of a medicament for the treatment of congestive heart failure |
| 05/12/1999 | EP0735888A4 Purine compositions and methods for administration |
| 05/12/1999 | EP0733067B1 N-terminally chemically modified protein compositions and methods |
| 05/12/1999 | EP0683672B1 Extract from flowers of salvia officinalis, process for its preparation and use thereof |
| 05/12/1999 | EP0628046B1 Triazolopyrimidin derivatives as antiotensin ii receptor antagonists |
| 05/12/1999 | EP0592553B1 Pla2 inhibitory compounds |
| 05/12/1999 | CN1216531A Indole derivatives useful as endothelin receptor antagonists |
| 05/12/1999 | CN1043349C New sulfuric acid esters of sugar alcohols and producing process and its application |
| 05/12/1999 | CN1043348C Asymmetrically substituted xanthines its producting process and its application as pharmaceutical composition |
| 05/11/1999 | US5902831 Administering reduced nicotinamide-adenine dinucleotide phosphate oxidase inhibitor to treat condition resulting from endothelial hyperpermeability |
| 05/11/1999 | US5902830 Lowering plasma cholesterol levels |
| 05/11/1999 | US5902811 Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions |
| 05/11/1999 | US5902810 Pteridine derivatives as no synthase inhibitors |
| 05/11/1999 | US5902803 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 05/11/1999 | US5902791 Metalloproteinase inhibitors |
| 05/11/1999 | US5902790 Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
| 05/11/1999 | CA2160874C Nasal aromatic releasing compositions |
| 05/06/1999 | WO1999022243A1 148 human secreted proteins |
| 05/06/1999 | WO1999021857A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 05/06/1999 | WO1999021843A1 4, 5-diaryloxazole compounds |
| 05/06/1999 | WO1999021834A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 05/06/1999 | WO1999021831A1 Tricyclic compounds as cgmp-pde inhibitors |
| 05/06/1999 | WO1999021829A1 Dofetilide polymorphs |
| 05/06/1999 | WO1999021617A2 Allosteric adenosine receptor modulators |
| 05/06/1999 | WO1999021590A1 Gene therapy for stimulation of angiogenesis |
| 05/06/1999 | WO1999021570A1 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 05/06/1999 | WO1999021565A1 Nutritional supplement for cerebral metabolic insufficiencies |
| 05/06/1999 | WO1999021564A1 Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method |
| 05/06/1999 | WO1999021562A1 Treatment of female sexual dysfunction |
| 05/06/1999 | WO1999021546A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
| 05/06/1999 | WO1999021535A1 Osmotic medicament releasing system |
| 05/06/1999 | WO1999015493A8 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 05/06/1999 | WO1999013920A3 Method for treating proliferative diseases by therapy |
| 05/06/1999 | WO1999013054A3 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 05/06/1999 | WO1998054301B1 Transplants for myocardial scars and method and cellular preparations therefor |
| 05/06/1999 | EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB) |
| 05/06/1999 | EP0913477A2 LacC gene encoding a tagatose-6-phosphate kinase |
| 05/06/1999 | EP0913472A2 Human LIG-1 Homolog (HLIG-1) |
| 05/06/1999 | EP0913396A2 Sulphonamide substituted benzopyran derivatives, process of preparation, their use as medicines and pharmaceutical compositions containing them |
| 05/06/1999 | EP0913155A2 Pharmaceutical formulation for treating liver disorders |
| 05/06/1999 | EP0912747A1 Aspartic protease |
| 05/06/1999 | EP0912741A2 T-cell selective interleukin-4 agonists |
| 05/06/1999 | EP0912567A1 Carboline derivatives |
| 05/06/1999 | EP0912551A1 Somatostatin agonists and antagonists |